European Commission logo
English English
CORDIS - EU research results
CORDIS

BIONIC FEEDBACK SYSTEM FOR AMPUTEES AND DIABETICS

Project description

Bionic feedback system to restore feeling in the legs

In Europe alone, it has been estimated that there are approximately 1.5 million amputees and 7.5 million people who suffer from polyneuropathy and serious sensory problems. Apart from putting great strain on the healthcare system, these conditions also severely affect quality of life. The EU-funded BFS project aims to improve the quality of life of people who lack feeling in their legs, whether as a result of polyneuropathy or amputation. The solution involves a bionic feedback system comprising a sensor sole and a transmission part applied on the stump or leg. This system will help affected persons reclaim the feeling of the missing or damaged leg, providing the brain with the sensory information it had lost.

Objective

The BIONIC FEEDBACK SYSTEM. The Austrian company SAPHENUS Medical Technology, founded in 2016, has set itself
the goal of improving the quality of people who lack the feeling in the legs, whether through polyneuropathy or through
amputation. 1,5 million amputees and 7,5 million people with polyneuropathy and serious sensory problems are affected all
over Europe. For these two target groups SAPHENUS has the breakthrough solution using the bionic principle. With the
Bionic Feedback System (BFS) the affected persons get back the feeling of the lost or damaged foot, they feel authentic
again, and the brain is provided with sensory information again. SURALIS and CUTANEUS, the two BFS-products of SAPHENUS
are patented high-tec add-on devices that consist of (i) a sensor sole and (ii) a transmission part which is applied on the
stump or leg. SURALIS and CUTANEUS represent a new medical product category supporting cost-efficient, affordable,
optimised care for amputees and diabetics. SAPHENUS has a strong network in medical research as well as in health
insurances and in distribution partners. The SME-Instrument phase 1 business plan shall now be further implemented. The
phase 2 workplan foresees a duration of 24 months and requests 1,8 mio of EC funding.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Funding Scheme

SME - SME instrument

Coordinator

SAPHENUS MEDICAL TECHNOLOGY GMBH
Net EU contribution
€ 1 806 000,00
Address
MAGNESITSTRASSE 1
3500 KREMS AN DER DONAU
Austria

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Ostösterreich Niederösterreich Waldviertel
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 580 000,00